Zawia3 · Chart 7 of 7

New originator drug pricing tiers by factory price

Three tiers: below 50k, between 50k and 500k, and above 500k EGP

“If the price falls between 50,000 and 500,000 pounds it moves to value-based pricing; if it exceeds 500,000 it is priced at the lowest price in the countries where it is marketed.”
Below 50,000 EGP ($1,035) Low tier

Lowest price among 15 reference countries

Standard external reference pricing mechanism

50,000 – 500,000 EGP Mid tier

Value-based pricing (therapeutic value)

Requires health economics studies submitted by the manufacturer

Above 500,000 EGP ($10,352) High tier

Lowest price in countries where the drug is actually marketed

No restriction to the list of 15 — cancer treatments and similar

Source: Egyptian Drug Authority Decision No. 480 of 2026 — Article 3